KPIs & Operating Metrics(New)

Gsk (GSK) Total Debt (2009 - 2026)

Gsk (GSK) posted Total Debt of $23.6 billion for Q4 2025, up 8.3% on a QoQ basis from $21.8 billion in Q4 2024, and up 8.3% year-over-year from $21.8 billion in Q4 2024.

Gsk (GSK) has 10 years of Total Debt data on file, last reported at $23.6 billion in Q4 2025.

  • In Q4 2025, Total Debt rose 8.3% year-over-year to $23.6 billion; the TTM figure through Dec 2025 stood at $23.6 billion (up 8.3% YoY), while the FY2025 annual figure was $23.6 billion, up 8.3% from the prior year.
  • Total Debt improved to $23.6 billion in Q4 2025, from $21.8 billion in the prior quarter.
  • Across five years, Total Debt topped out at $29.1 billion in Q4 2021 and bottomed at $21.5 billion in Q4 2022.
  • A 5-year average of $23.6 billion and a median of $22.3 billion in 2023 frame the typical range for Total Debt.
  • Annual changes were most pronounced in 2022 — Total Debt fell 26.04% — and 2025, when it gained 8.3%.
  • Year by year, Total Debt stood at $29.1 billion in 2021, then declined by 26.04% to $21.5 billion in 2022, then increased by 3.97% to $22.3 billion in 2023, then dropped by 2.65% to $21.8 billion in 2024, then rose by 8.3% to $23.6 billion in 2025.
  • The last three Total Debt figures came in at $23.6 billion (Q4 2025), $21.8 billion (Q4 2024), and $22.3 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 43.37 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 54.99 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 64.53 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 49.12 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 57.32 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 22.17 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 64.46 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 44.46 Bn
10 Gsk 88.34 Bn 83.66 Bn - 23.56 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26.01 Bn
Dec 31, 2025 -26.73 Bn
Sep 30, 2025 -27.58 Bn
Jun 30, 2025 -27.68 Bn
Mar 31, 2025 -28.12 Bn
Dec 31, 2024 21.75 Bn
Sep 30, 2024 -25.03 Bn
Jun 30, 2024 -24.76 Bn
Mar 31, 2024 -26.81 Bn
Dec 31, 2023 22.35 Bn
Sep 30, 2023 -27.21 Bn
Jun 30, 2023 -26.07 Bn
Mar 31, 2023 -27.06 Bn
Dec 31, 2022 21.49 Bn
Sep 30, 2022 -30.27 Bn
Jun 30, 2022 -30.55 Bn
Mar 31, 2022 -19.54 Bn
Dec 31, 2021 29.06 Bn
Sep 30, 2021 -35.54 Bn
Jun 30, 2021 -35.58 Bn
Mar 31, 2021 -38.76 Bn
Dec 31, 2020 31.94 Bn
Jun 30, 2020 -38.18 Bn
Mar 31, 2020 -38.00 Bn
Dec 31, 2019 31.30 Bn
Sep 30, 2019 -37.15 Bn
Jun 30, 2019 -36.69 Bn
Mar 31, 2019 -37.12 Bn
Dec 31, 2018 33.54 Bn
Sep 30, 2018 -39.39 Bn
Jun 30, 2018 -40.81 Bn
Mar 31, 2018 -26.28 Bn
Dec 31, 2017 21.25 Bn
Sep 30, 2017 -25.25 Bn
Jun 30, 2017 -22.29 Bn
Mar 31, 2017 -24.53 Bn
Dec 31, 2016 23.36 Bn
Sep 30, 2016 -26.55 Bn
Jun 30, 2016 -28.17 Bn
Mar 31, 2016 -22.57 Bn
Dec 31, 2015 -23.25 Bn
Sep 30, 2015 -23.42 Bn
Jun 30, 2015 -22.49 Bn
Mar 31, 2015 -23.09 Bn
Dec 31, 2014 -25.10 Bn
Sep 30, 2014 -22.77 Bn
Jun 30, 2014 -26.34 Bn
Mar 31, 2014 -25.45 Bn
Dec 31, 2013 -26.79 Bn
Sep 30, 2013 -24.27 Bn
Jun 30, 2013 -26.37 Bn
Mar 31, 2013 -26.89 Bn
Dec 31, 2012 464.10 Mn
Sep 30, 2012 -21.05 Bn
Jun 30, 2012 -21.50 Bn
Mar 31, 2012 -18.84 Bn
Dec 31, 2011 465.18 Mn
Sep 30, 2011 -22.88 Bn
Jun 30, 2011 -23.20 Bn
Mar 31, 2011 -23.75 Bn
Dec 31, 2010 -23.40 Bn
Sep 30, 2010 -23.03 Bn
Jun 30, 2010 -22.16 Bn
Mar 31, 2010 -23.75 Bn
Dec 31, 2009 -24.15 Bn
Sep 30, 2009 -24.67 Bn
Jun 30, 2009 -20.23 Bn
Mar 31, 2009 -21.71 Bn